Pegylated Interferon Alfa-2a for Dialysis Patients With Acute Hepatitis C

NCT00917358 · clinicaltrials.gov ↗

PHASE4

Phase

COMPLETED

Status

42

Enrollment

OTHER

Sponsor class

Conditions

Hepatitis C

Interventions

DRUG: Pegylated interferon alfa-2a

Sponsor

National Taiwan University Hospital

Collaborators

[object Object]